UBS Group’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5K | Sell |
3,692
-16,413
| -82% | -$131K | ﹤0.01% | 6866 |
|
|
2025
Q1 | $196K | Buy |
20,105
+1,396
| +7% | +$13.6K | ﹤0.01% | 5331 |
|
|
2024
Q4 | $236K | Buy |
18,709
+15,103
| +419% | +$191K | ﹤0.01% | 5161 |
|
|
2024
Q3 | $58K | Buy |
3,606
+32
| +0.9% | +$515 | ﹤0.01% | 5524 |
|
|
2024
Q2 | $87.2K | Sell |
3,574
-3,372
| -49% | -$82.3K | ﹤0.01% | 5142 |
|
|
2024
Q1 | $499K | Sell |
6,946
-4,305
| -38% | -$309K | ﹤0.01% | 4103 |
|
|
2023
Q4 | $2.24M | Buy |
11,251
+6,963
| +162% | +$1.38M | ﹤0.01% | 2744 |
|
|
2023
Q3 | $570K | Sell |
4,288
-1,637
| -28% | -$218K | ﹤0.01% | 3521 |
|
|
2023
Q2 | $886K | Sell |
5,925
-176
| -3% | -$26.3K | ﹤0.01% | 3401 |
|
|
2023
Q1 | $896K | Sell |
6,101
-6,367
| -51% | -$935K | ﹤0.01% | 3277 |
|
|
2022
Q4 | $1.97M | Buy |
12,468
+11,029
| +766% | +$1.75M | ﹤0.01% | 2569 |
|
|
2022
Q3 | $277K | Buy |
1,439
+1,103
| +328% | +$212K | ﹤0.01% | 3826 |
|
|
2022
Q2 | $49K | Sell |
336
-5,284
| -94% | -$771K | ﹤0.01% | 4920 |
|
|
2022
Q1 | $989K | Sell |
5,620
-4,144
| -42% | -$729K | ﹤0.01% | 3238 |
|
|
2021
Q4 | $2.87M | Buy |
9,764
+8,985
| +1,153% | +$2.64M | ﹤0.01% | 2590 |
|
|
2021
Q3 | $193K | Buy |
779
+7
| +0.9% | +$1.73K | ﹤0.01% | 4306 |
|
|
2021
Q2 | $196K | Sell |
772
-350
| -31% | -$88.9K | ﹤0.01% | 4346 |
|
|
2021
Q1 | $199K | Buy |
1,122
+109
| +11% | +$19.3K | ﹤0.01% | 4521 |
|
|
2020
Q4 | $160K | Sell |
1,013
-1,414
| -58% | -$223K | ﹤0.01% | 4407 |
|
|
2020
Q3 | $626K | Buy |
2,427
+481
| +25% | +$124K | ﹤0.01% | 3240 |
|
|
2020
Q2 | $451K | Buy |
1,946
+1,747
| +878% | +$405K | ﹤0.01% | 3474 |
|
|
2020
Q1 | $34K | Sell |
199
-168
| -46% | -$28.7K | ﹤0.01% | 5231 |
|
|
2019
Q4 | $81K | Buy |
+367
| New | +$81K | ﹤0.01% | 5064 |
|